Emergency coronary bypass grafting for failed percutaneous coronary artery stenting: increased costs and platelet transfusion requirements after the use of abciximab
- 28 February 1998
- journal article
- case report
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 115 (2) , 472-473
- https://doi.org/10.1016/s0022-5223(98)70296-x
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Preventing Coronary Restenosis and ComplicationsNew England Journal of Medicine, 1997
- Effects of profound platelet inhibition with c7E3 before coronary angioplasty on complications of coronary bypass surgeryThe American Journal of Cardiology, 1994
- Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary AngioplastyNew England Journal of Medicine, 1994
- Coronary Artery Bypass Following Percutaneous Transluminal Coronary AngioplastyThe Annals of Thoracic Surgery, 1985